BIOMET GETS FDA CLEARANCE FOR REGENEREX ACETABULAR SYSTEM

Biomet Inc. (BMET) received regulatory clearance from the Food and Drug Administration for its Regenerex porous titanium construct acetabular system for primary and revision hip surgery. The Warsaw, Ind., orthopedic products company said it will launch Regenerex in the first half of its 2007 fiscal year. Market Watch (http://www.marketwatch.com/News/Story/Story.aspx?dist=newsfinder&siteid=google&guid=%7B946B4EB4-4E8A-4320-B475-A56D4AE02EBC%7D&keyword=)